Marie de Tersant

ORCID: 0000-0003-2492-9802
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pancreatitis Pathology and Treatment
  • Electrolyte and hormonal disorders
  • Muscle and Compartmental Disorders
  • DNA Repair Mechanisms
  • Fungal Infections and Studies
  • Adrenal and Paraganglionic Tumors
  • Cancer Genomics and Diagnostics
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Hormonal Regulation and Hypertension
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia research
  • Antifungal resistance and susceptibility
  • Hematopoietic Stem Cell Transplantation
  • Cancer-related Molecular Pathways
  • Cancer, Hypoxia, and Metabolism

Assistance Publique – Hôpitaux de Paris
2021-2025

Hôpital Robert-Debré
2017-2025

Université Paris Cité
2021-2023

Institut de recherche Saint-Louis
2023

Hôpital Saint-Louis
2023

Université Paris-Saclay
2020

Institut Gustave Roussy
2020

The purpose of this work is to assess the clinical outcome pediatric patients diagnosed with pheochromocytoma and paraganglioma (PPGL) detected in France since 2000.A retrospective multicenter study was conducted that included all younger than 18 years PPGL between 2000 2016. Patients were identified from 4 different sources: National Registry Childhood Solid Tumors, French Pediatric Rare Tumors Database, registry succinate dehydrogenase (SDH)-related hereditary paraganglioma, nationwide...

10.1210/jendso/bvaa039 article EN cc-by-nc-nd Journal of the Endocrine Society 2020-04-03

Introduction Total body irradiation associated with etoposide is widely used in conditioning regimens before hematologic stem cell transplantation (HSCT). The formulation exposes children to a high dose of ethanol, and data on its side effects are scarce. We investigated whether paediatric patients acute lymphoid leukaemia lymphoblastic lymphoma were experiencing hypersensitivity reactions or ethanol-related after infusion HSCT. Methods This study retrospectively analyzed all treated TBI 12...

10.1177/10781552251330244 article EN Journal of Oncology Pharmacy Practice 2025-04-16

This work’s objective was to evaluate the safety of isavuconazole (ISA) as a treatment or prophylaxis for invasive fungal infections (IFIs) in immunocompromised children. IFI reported proven probable according international definitions. Therapeutic drug monitoring performed using mass tandem spectrometry quantify trough plasma concentrations. Targeted ISA levels were 2−4 mg/L, adult series. Nine patients received curative treatment, and six prophylaxis. IFIs four cases five. The median...

10.3390/ph15030375 article EN cc-by Pharmaceuticals 2022-03-19
Coming Soon ...